// App-Quantinova.ai

THU0001 (2018) : Differential methylation as a predictor of methotrexate response in patients with rheumatoid arthritis

Researchers

Presenter

  • N. Nair

Principal Investigators

  • D. Plant

  • S.M. Verstappen

  • J.D. Isaacs

  • A.W. Morgan

  • K.L. Hyrich

  • A. Barton

  • A.G. Wilson

Medical Centers

  • Arthritis Research UK Centre for Genetics and Genomics, University of Manchester

  • NIHR Manchester Musculoskeletal BRC, CMFT

  • Arthritis Research UK Centre for Genetics and Genomics, University of Manchester, Manchester, United Kingdom

  • NIHR Newcastle BRC, Newcastle upon Tyne Hospitals NHS Foundation Trust and Newcastle University, Newcastle

  • University College Dublin School of Medicine and Medical Science, University College Dublin, Dublin, Ireland

Locations

  • United States

  • South Africa

  • United Kingdom

  • Ireland

Companies

  • N/A

Study Components

Therapeutic Area

  • Autoimmune (AI)

Disease

  • Rheumatoid arthritis

Biomarkers

  • DNA methylation

Drug/Treatment

  • Methotrexate

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved